交易 First Wave BioPharma, Inc. - FWBI CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.0620 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 0.001 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Mar 28, 2024 | 4.3890 | 0.4900 | 12.57% | 3.8990 | 4.5190 | 3.8090 |
Mar 27, 2024 | 3.9090 | -0.0900 | -2.25% | 3.9990 | 4.0590 | 3.8090 |
Mar 26, 2024 | 3.9590 | -0.0400 | -1.00% | 3.9990 | 4.0690 | 3.8990 |
Mar 25, 2024 | 4.1190 | -0.2800 | -6.37% | 4.3990 | 4.3990 | 3.9990 |
Mar 22, 2024 | 4.2490 | -0.2400 | -5.35% | 4.4890 | 4.4890 | 4.2490 |
Mar 21, 2024 | 4.4190 | -0.2100 | -4.54% | 4.6290 | 4.6290 | 4.2490 |
Mar 20, 2024 | 4.5190 | -0.3400 | -7.00% | 4.8590 | 4.8990 | 4.3990 |
Mar 19, 2024 | 4.8490 | 0.1000 | 2.11% | 4.7490 | 5.0590 | 4.7490 |
Mar 18, 2024 | 4.8790 | 0.2700 | 5.86% | 4.6090 | 4.9490 | 4.3890 |
Mar 15, 2024 | 4.7790 | -0.1600 | -3.24% | 4.9390 | 5.1990 | 4.6990 |
Mar 14, 2024 | 5.3090 | -0.7200 | -11.94% | 6.0290 | 6.0290 | 4.6790 |
Mar 13, 2024 | 6.5290 | 0.7300 | 12.59% | 5.7990 | 6.7990 | 5.6790 |
Mar 12, 2024 | 5.6690 | -0.2300 | -3.90% | 5.8990 | 5.9890 | 5.2890 |
Mar 11, 2024 | 5.8790 | -1.1400 | -16.24% | 7.0190 | 7.0190 | 5.5290 |
Mar 8, 2024 | 6.7890 | -0.3100 | -4.37% | 7.0990 | 7.1990 | 6.7890 |
Mar 7, 2024 | 7.0790 | -0.1400 | -1.94% | 7.2190 | 7.5290 | 6.8890 |
Mar 6, 2024 | 7.3090 | -0.5000 | -6.40% | 7.8090 | 7.8090 | 7.0490 |
Mar 5, 2024 | 7.7990 | 0.8800 | 12.72% | 6.9190 | 8.1290 | 6.9190 |
Mar 4, 2024 | 6.9190 | -0.9800 | -12.41% | 7.8990 | 8.3990 | 6.9190 |
Mar 1, 2024 | 9.0090 | 1.1200 | 14.20% | 7.8890 | 9.2990 | 7.8090 |
First Wave BioPharma, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Friday, March 29, 2024 | ||
时间(协调世界时) (UTC) 20:00 | 国家 US
| 事件 Q4 2023 First Wave BioPharma Inc Earnings Release Q4 2023 First Wave BioPharma Inc Earnings ReleaseForecast(预报) -上一页 - |
Sunday, May 12, 2024 | ||
时间(协调世界时) (UTC) 20:00 | 国家 US
| 事件 Q1 2024 First Wave BioPharma Inc Earnings Release Q1 2024 First Wave BioPharma Inc Earnings ReleaseForecast(预报) -上一页 - |
Friday, June 21, 2024 | ||
时间(协调世界时) (UTC) 13:00 | 国家 US
| 事件 First Wave BioPharma Inc Annual Shareholders Meeting First Wave BioPharma Inc Annual Shareholders MeetingForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 12.6781 | 59.0569 | 26.8313 | 14.7437 | 13.4318 |
銷售/一般/行政費用,總計 | 11.9868 | 18.3696 | 7.27976 | 6.04227 | 8.17431 |
研究與開發 | 8.7763 | 38.3204 | 19.105 | 7.85849 | 4.98555 |
Depreciation / Amortization | 0.015 | 0.048 | 0.84299 | 0.06191 | |
Other Operating Expenses, Total | -8.08505 | 0 | 0.21 | ||
營業收入 | -12.6781 | -59.0569 | -26.8313 | -14.7437 | -13.4318 |
利息收入(費用),非經營淨值 | -0.00746 | -0.01007 | -5.84013 | -0.43394 | -0.10185 |
其他,淨值 | -1.94411 | 0.5291 | |||
稅前淨收入 | -14.6296 | -58.5378 | -32.6715 | -15.1777 | -13.5336 |
稅後淨收入 | -14.6296 | -58.5378 | -32.6715 | -15.1777 | -13.5336 |
未計算非常項目前的淨收益 | -14.6296 | -58.5378 | -32.6715 | -15.1777 | -13.5336 |
淨收入 | -14.6296 | -58.5378 | -32.6715 | -15.1777 | -13.5336 |
普通股股東可獲收益 (不含非經常性項目) | -14.9731 | -84.5186 | -41.7323 | -15.1777 | -13.5336 |
普通股股東可獲收益 (含非經常性項目) | -14.9731 | -84.5186 | -41.7323 | -15.1777 | -13.5336 |
攤薄淨收入 | -14.9731 | -84.5186 | -41.7323 | -15.1777 | -13.5336 |
攤薄後加權平均股 | 0.71825 | 0.0425 | 0.01354 | 0.01068 | 0.00735 |
扣除特別項目的每股攤薄盈利 | -20.8466 | -1988.67 | -3082.15 | -1421.4 | -1840.94 |
每股正常攤薄盈利 | -20.8466 | -1933.33 | -3052.71 | -1421.4 | -1840.94 |
收入 | 0 | ||||
異常費用(收入) | 0 | 2.35199 | 0.39857 | ||
Total Adjustments to Net Income | -0.34343 | -25.9807 | -9.06087 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 4.18164 | 4.06243 | 2.27967 | -4.38953 | 14.7879 |
銷售/一般/行政費用,總計 | 2.82855 | 2.70074 | 2.17785 | 2.90445 | 6.90451 |
研究與開發 | 1.3531 | 1.36168 | 0.10182 | 0.79107 | 7.88341 |
Depreciation / Amortization | |||||
營業收入 | -4.18164 | -4.06243 | -2.27967 | 4.38953 | -14.7879 |
利息收入(費用),非經營淨值 | -0.00497 | -0.00712 | -0.0015 | 0.0018 | -0.00775 |
其他,淨值 | -0.00262 | -0.00111 | -1.70481 | 0 | -0.2393 |
稅前淨收入 | -4.18923 | -4.07065 | -3.98599 | 4.39133 | -15.035 |
稅後淨收入 | -4.18923 | -4.07065 | -3.98599 | 4.39133 | -15.035 |
未計算非常項目前的淨收益 | -4.18923 | -4.07065 | -3.98599 | 4.39133 | -15.035 |
淨收入 | -4.18923 | -4.07065 | -3.98599 | 4.39133 | -15.035 |
Total Adjustments to Net Income | -0.09432 | -0.08743 | 0.00207 | -0.15758 | -0.18792 |
普通股股東可獲收益 (不含非經常性項目) | -4.28356 | -4.15808 | -3.98392 | 4.23375 | -15.2229 |
普通股股東可獲收益 (含非經常性項目) | -4.28356 | -4.15808 | -3.98392 | 4.23375 | -15.2229 |
攤薄淨收入 | -4.28356 | -4.15808 | -3.98392 | 4.23375 | -15.2229 |
攤薄後加權平均股 | 2.27092 | 2.28068 | 0.71825 | 0.23225 | 0.18244 |
扣除特別項目的每股攤薄盈利 | -1.88626 | -1.82318 | -5.54671 | 18.2291 | -83.4388 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.88626 | -1.82318 | -5.54671 | 18.2291 | -83.4388 |
異常費用(收入) | 0 | ||||
Other Operating Expenses, Total | 0 | 0 | -8.08505 | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 3.41276 | 9.42495 | 7.86978 | 3.40829 | 4.8 |
現金和短期投資 | 1.36291 | 8.24868 | 6.06214 | 0.1758 | 1.11434 |
现金 | 1.36291 | 8.24868 | 6.06214 | 0.1758 | 1.11434 |
短期投資 | |||||
應收賬款總額,淨額 | 0.09301 | 0 | 0.55149 | 2.6373 | 3.17268 |
預付的費用 | 1.95683 | 1.17627 | 1.25615 | 0.59519 | 0.51298 |
總資産 | 5.4397 | 11.79 | 12.9239 | 8.90288 | 7.4694 |
物業/廠房/設備,總計 - 淨額 | 0.3031 | 0.40931 | 0.09257 | 0.15978 | 0.12885 |
商譽,淨額 | 1.68418 | 1.91171 | 2.05405 | 1.88669 | 1.92483 |
無形資産,淨額 | 0 | 2.87954 | 3.40708 | 0.57048 | |
其他長期資産,總計 | 0.03966 | 0.04401 | 0.02792 | 0.04105 | 0.04523 |
流動負債總額 | 2.48349 | 12.3004 | 15.5454 | 4.28564 | 2.99552 |
Payable/Accrued | 0 | 0.53343 | 0.6701 | ||
預提費用 | 0.38633 | 0.49706 | 0.18443 | 0.15441 | 0.53829 |
應付票據/短期債務 | 0.60349 | 0.64124 | 0.55241 | 1.5213 | 0.25503 |
其他流動負債,總計 | 0.77363 | 8.48018 | 13.25 | 0.39299 | |
負債總額 | 2.69755 | 19.6115 | 15.5646 | 4.28564 | 2.99552 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 0.21406 | 7.31114 | 0.01912 | 0 | 0 |
總權益 | 2.74215 | -7.82155 | -2.64069 | 4.61724 | 4.47387 |
普通股 | 0.0001 | 0.00149 | 0.00312 | 0.00268 | 0.00177 |
額外實收資本 | 171.276 | 147.305 | 93.8349 | 68.5759 | 53.1393 |
留存收益(累計赤字) | -168.534 | -153.904 | -95.3662 | -62.6947 | -47.5171 |
其他權益,總計 | 0 | -1.22414 | -1.11255 | -1.26656 | -1.15011 |
總負債和股東權益 | 5.4397 | 11.79 | 12.9239 | 8.90288 | 7.4694 |
已發行普通股總數 | 0.995 | 0.07074 | 0.01483 | 0.01276 | 0.00843 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
物業/廠房/設備,總計 - 總額 | 0.34708 | 0.42402 | 0.13097 | 0.4233 | 0.33225 |
累計折舊,總計 | -0.04398 | -0.01471 | -0.0384 | -0.26352 | -0.20339 |
應付賬款 | 0.72004 | 2.68191 | 1.55859 | 1.68351 | 1.53211 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 3.9766 | 2.35379 | 3.52987 | 3.41276 | 2.54914 |
現金和短期投資 | 3.29233 | 1.23605 | 2.06444 | 1.36291 | 1.65701 |
现金 | 3.29233 | 1.23605 | 2.06444 | 1.36291 | 1.65701 |
應收賬款總額,淨額 | 0 | 0 | 0.02 | 0.09301 | 0.19198 |
預付的費用 | 0.68427 | 1.11774 | 1.44544 | 1.95683 | 0.56146 |
總資産 | 5.92727 | 4.32787 | 5.53398 | 5.4397 | 4.6454 |
物業/廠房/設備,總計 - 淨額 | 0.23372 | 0.25713 | 0.28025 | 0.3031 | 0.32567 |
物業/廠房/設備,總計 - 總額 | 0.29965 | 0.31575 | 0.33155 | 0.34708 | 0.36233 |
累計折舊,總計 | -0.06593 | -0.05862 | -0.0513 | -0.04398 | -0.03666 |
商譽,淨額 | 1.68418 | 1.68418 | 1.68418 | 1.68418 | 1.71479 |
無形資産,淨額 | |||||
其他長期資産,總計 | 0.03277 | 0.03277 | 0.03967 | 0.03966 | 0.0558 |
流動負債總額 | 2.48249 | 3.26125 | 2.62486 | 2.48349 | 6.69416 |
應付賬款 | 0.57929 | 1.5912 | 0.46976 | 0.72004 | 3.58299 |
預提費用 | 0.89986 | 0.54343 | 0.91366 | 0.38633 | 0.33667 |
應付票據/短期債務 | 0 | 0.15348 | 0.38039 | 0.60349 | 0 |
其他流動負債,總計 | 1.00334 | 0.97315 | 0.86104 | 0.77363 | 2.77451 |
負債總額 | 2.64846 | 3.44591 | 2.82138 | 2.69755 | 6.92545 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 0.16597 | 0.18466 | 0.19652 | 0.21406 | 0.23129 |
總權益 | 3.27881 | 0.88196 | 2.7126 | 2.74215 | -2.28005 |
普通股 | 0.00135 | 0.00042 | 0.00016 | 0.0001 | 0.00023 |
額外實收資本 | 183.505 | 177.675 | 175.317 | 171.276 | 163.722 |
留存收益(累計赤字) | -180.228 | -176.794 | -172.604 | -168.534 | -164.548 |
其他權益,總計 | 0 | -1.45472 | |||
總負債和股東權益 | 5.92727 | 4.32787 | 5.53398 | 5.4397 | 4.6454 |
已發行普通股總數 | 13.4635 | 4.209 | 1.54958 | 0.995 | 0.32958 |
Preferred Stock - Non Redeemable, Net | |||||
其他流動資産,總計 | 0.13868 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -14.6296 | -58.5378 | -32.6715 | -15.1777 | -13.5336 |
经营活动产生的现金 | -22.3441 | -32.2882 | -11.2215 | -14.0335 | -10.8693 |
经营活动产生的现金 | 0.02927 | 0.01471 | 0.0378 | 0.0631 | 0.06191 |
Amortization | 0 | 0.52755 | 0.52755 | 0.95695 | 0.73654 |
非现金物品 | 2.75792 | 8.60641 | 6.73365 | 1.82513 | 3.57765 |
营运资金的变化 | -10.5016 | 17.101 | 14.1509 | -1.70099 | -1.7118 |
投资活动产生的现金 | 0 | -10.3195 | 0.08735 | -0.0241 | -0.30547 |
资本支出 | 0 | -0.06949 | -0.00417 | -0.0241 | -0.30547 |
融资活动产生的现金 | 15.7395 | 44.7635 | 17.0461 | 13.145 | 11.7121 |
融资现金流项目 | -6.91496 | ||||
股票的发行(报废),净额 | 23.2957 | 44.6747 | 14.1861 | 9.53834 | 11.9028 |
债务的发行(退还),净额 | -0.64124 | 0.08883 | 2.86003 | 3.60664 | -0.19068 |
外汇效应 | -0.25971 | 0.03076 | -0.02559 | -0.02593 | 0.00354 |
现金净变化 | -6.86426 | 2.18654 | 5.88635 | -0.93855 | 0.54087 |
Cash Taxes Paid | 0 | 0 | 0 | ||
已付现金利息 | 0.01588 | 0 | 0.10546 | 0.00803 | 0.00401 |
其他投资现金流量项目,总计 | 0 | -10.25 | 0.09152 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -4.07065 | -14.6296 | -10.6437 | -15.035 | -9.62684 |
Cash From Operating Activities | -2.84558 | -22.3441 | -16.7518 | -12.4977 | -7.91207 |
Cash From Operating Activities | 0.00732 | 0.02927 | 0.02195 | 0.01464 | 0.00732 |
Amortization | 0 | 0 | 0 | 0 | 0 |
Non-Cash Items | 0.37384 | 2.75792 | 0.86545 | 0.75883 | 0.36042 |
Cash Interest Paid | 0.00899 | 0.01588 | |||
Changes in Working Capital | 0.84391 | -10.5016 | -6.99554 | 1.76384 | 1.34703 |
Cash From Investing Activities | 0 | 0 | 0 | ||
Capital Expenditures | 0 | 0 | 0 | ||
Cash From Financing Activities | 3.54711 | 15.7395 | 10.2153 | 5.44352 | 5.36715 |
Financing Cash Flow Items | 0 | -6.91496 | -5.05364 | -2.41496 | -2.41496 |
Issuance (Retirement) of Stock, Net | 3.77021 | 23.2957 | 15.9102 | 8.3378 | 8.02057 |
Issuance (Retirement) of Debt, Net | -0.2231 | -0.64124 | -0.64124 | -0.47933 | -0.23847 |
Foreign Exchange Effects | 0 | -0.25971 | -0.03367 | -0.03952 | -0.00877 |
Net Change in Cash | 0.70153 | -6.86426 | -6.57017 | -7.09368 | -2.5537 |
Cash Taxes Paid | |||||
Other Investing Cash Flow Items, Total | 0 | 0 | 0 |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
First Wave BioPharma, Inc. Company profile
关于 First Wave BioPharma Inc.
第一波生物制药公司,前身是AzurRx生物制药公司,是一家临床阶段的生物制药公司。 它从事胃肠道(GI)疾病的靶向、非系统疗法的开发。 该公司专注于推进围绕其两项技术建立的治疗开发管道:尼可刹米,一种具有抗病毒和抗炎特性的口服小分子,以及生物制剂adrulipase,一种重组脂肪酶,旨在使脂肪和其他营养物质得到消化。 公司的烟酰胺产品组合由三个临床项目主导。 FW-COV,治疗COVID-19胃肠道感染;FW-UP,治疗溃疡性直肠炎(UP)和溃疡性直肠乙状结肠炎;FW-ICI-AC,治疗晚期肿瘤患者的1级和2级免疫检查点抑制剂相关的结肠炎和腹泻。 该公司还在推进FW-EPI(阿曲酶),用于治疗囊性纤维化和慢性胰腺炎患者的外分泌胰腺功能不全(EPI)。
Industry: | Biotechnology & Medical Research (NEC) |
777 Yamato Road
Suite 502
BOCA RATON
FLORIDA 33431
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球580,000万多名交易者的一份子,选择利用Capital.com进行交易吧。